BeStock  
Stocks › Medical Devices › VREX

Varex Imaging VREX

US equityMarket cap rank #3425Medical Devices
$18.44 −$0.04 (-0.22%)
Pre-market · Oct 8, 7:00 am ET · After hours $18.44 0.00%
Open$18.47
Prev close$18.48
Day range$18.42 – $18.49
Volume601.1K
Market cap$783.03M
P/E (TTM)34.8
Dividend yield–

Earnings

Average move on report day±10.3%last 16 reports
Closed higher5 of 1631% of the time
Best reaction+21.4%
Worst reaction-20.5%

Stock move on the day after each report

-0.8%2023/Q4-9.2%2024/Q1-5.1%2024/Q2-9.0%2024/Q3+5.9%2024/Q4-19.3%2025/Q1-20.5%2025/Q2+21.4%2025/Q3-13.7%2025/Q4-3.8%2026/Q1-16.9%2026/Q2+0.7%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q310 Aug 2026None±14.1%+0.65%Within range
2026/Q27 May 2026After Market±14.2%-16.91%Bigger than priced
2026/Q110 Feb 2026After Market±16.5%-3.82%Within range
2025/Q418 Nov 2025After Market±18.8%-13.66%Within range
2025/Q37 Aug 2025After Market±11.8%+21.38%Bigger than priced
2025/Q28 May 2025After Market±14.1%-20.46%Bigger than priced
2025/Q16 Feb 2025After Market±18.3%-19.28%Bigger than priced
2024/Q419 Nov 2024After Market±13.1%+5.91%Within range
2024/Q31 Aug 2024After Market±8.1%-9.04%Bigger than priced
2024/Q22 May 2024After Market±15.8%-5.11%Within range
2024/Q16 Feb 2024After Market±13.5%-9.21%Within range
2023/Q414 Nov 2023After Market±13.0%-0.82%Within range
2023/Q31 Aug 2023After Market±10.4%-2.61%Within range
2023/Q22 May 2023After Market±12.7%+19.46%Bigger than priced
2023/Q131 Jan 2023After Market±18.1%-12.47%Within range
2022/Q415 Nov 2022After Market±16.3%+3.81%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Medical$134.00M 63.7%
  • industrial$76.50M 36.3%

Fundamentals

Full statements →

Latest reported quarter: Q3, ended Jul 2026

Revenue$210.50M+3.7% YoY
Operating profit$22.80M+72.7% YoY
Net profit$15.90M+117.8% YoY
Diluted EPS$0.37+117.2% YoY
Free cash flow$12.00M+757.1% YoY
Operating cash flow$21.00M

Revenue, last 8 quarters

$205.7MSep '24$199.8MJan '25$212.9MApr '25$203.0MJul '25$228.9MOct '25$209.6MJan '26$216.0MApr '26$210.5MJul '26

Net profit, last 8 quarters

$-51.0MSep '24$-100.0KJan '25$7.1MApr '25$-89.1MJul '25$12.2MOct '25$2.4MJan '26$-8.0MApr '26$15.9MJul '26

Profitability & balance sheet

Gross margin34.3%
Operating margin8.3%
Net margin2.6%
Return on equity4.6%
Return on assets2.0%
Return on invested capital5.0%
Current ratio3.38
Liabilities / assets53.6%
Cash & investments$99.20M
Total debt$369.10M
Net cash (debt)-$269.90M

Discussion

No comments yet — be the first to weigh in on VREX.

Leave a comment

Scroll to Top